Your browser doesn't support javascript.
loading
Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report.
Srinivasan, Cindy; Shameli, Afshin; Ritchie, Bruce; Adatia, Adil.
Afiliação
  • Srinivasan C; Student, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Shameli A; Alberta Precision Laboratories, Calgary, Alberta, and Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Ritchie B; Division of Hematology, University of Alberta, Edmonton, Alberta, Canada.
  • Adatia A; Department of Medicine, Division of Pulmonary Medicine, University of Alberta, Edmonton, Alberta, Canada.
Immun Inflamm Dis ; 11(10): e1049, 2023 10.
Article em En | MEDLINE | ID: mdl-37904676
BACKGROUND: X-linked agammaglobulinemia (XLA) is the most common form of agammaglobulinemia and is caused by mutations in Btk, which encodes Bruton tyrosine kinase (BTK). CASE DESCRIPTION: We describe a 36-year-old male who presented as an infant with hypogammaglobulinemia and sinopulmonary infections and was initially diagnosed with common variable immunodeficiency. Genetic testing showed he was hemizygous for Btk c.240G > A. This synonymous variant affecting the last nucleotide of exon 3 leads to aberrant splicing of most but not all mRNA transcripts. CONCLUSION: We demonstrated reduced BTK protein expression confirming the pathogenicity of the variant and related our findings to genotype-phenotype relationship studies ina XLA caused by synonymous mutations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Agamaglobulinemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Agamaglobulinemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article